HeyJaredThe FDA Group's Insider Newsletter
The latest news and exclusive analysis across the FDA-regulated industries from former FDA professionals and industry experts. Save time gathering the critical industry intelligence you need to act on.
- Indexed issues, last 90 days
- 22
- Latest publication
- Sep 29, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 23, 2026
Latest issues
A Few Lessons From a Clean Contract Lab Vendor Audit (opens the original)
Read excerpt
<button class="pencraft p
4 Ways Quality Teams Are Augmenting Themselves With Full-Time Consultants (opens the original)
Read excerpt
<button class="pencraft pc-reset pen
Draft Guidance Breakdown: FDA Proposes Making eSTAR Mandatory for Certain PMA Submission Types (opens the original)
Read excerpt
<div class="p
RA/QA News Roll: Mid September 2026 (opens the original)
Read excerpt
<button class="pencraft pc-reset pen
Is Your Biotech De-Risking or Just Delaying? (opens the original)
Read excerpt
Subscribe to our podcast, The Life Science Rundown, if you haven’t already.Most preclinical companies, Baseimmune’s CEO Kevin Walton argues, are building their evidence backward. Cheap assays first, a run of supportive results, the expensive question deferred until the package looks respectable enough to survive it. Eighteen months later, the money is gone and the central hypothesis still hasn’t actually been tested.Kevin says thatR
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.